Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Issues related to the disease of diabetes, diabetes therapies, automated insulin delivery devices, and management of the disease of diabetes. Issues related to medical devices and medical device technologies. Issues related to Pharmacy Benefit Manager (PBM) reform proposals, PBM transparency and potential PBM proposals related to talks of future budget reconciliation package. Issues related to the reintroduction of the DIABETES Act (S.4037) in the 119th Congress. Issues related to artificial intelligence (AI) and predictive algorithms in medical devices and medical device technology. Issues related to tariffs and trade and the Sec. 232 Tariff investigation related to Medical Devices. Issues related to Local Coverage Determination revisions specifically in pathways for Continuous Glucose Monitors (CGM). Issues related to National Coverage Determination revisions specifically in reference to durable infusion insulin pumps. Issues related to Prior Authorizations in Medicare Advantage plans. Issues related to support of Improving Seniors' Timely Access to Care Act. Issues related to CMS finalized rule, DMEPOS Home Health Rule. Issues related to expansion of Competitive Bidding Program and implementation of CMS finalized rule relating to DMEPOS Home Health Rule. Issues related to wearable health care devices.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
INSULET CORPORATION via INSULET CORPORATION
2026 · third_quarter · Q3
Issues related to the disease of diabetes, diabetes therapies, automated insulin delivery devices, and management of the disease of diabetes. Issues related to medical devices and medical device technologies. Issues related to Pharmacy Benefit Manager (PBM) reform proposals, PBM transparency and potential PBM proposals related to talks of future budget reconciliation and/or year end package. Issues related to the DIABETES Act. Issues related to artificial intelligence (AI) and predictive algorithms in medical devices and medical device technology. Issues related to tariffs and trade and the Sec. 232 Tariff investigation related to Medical Devices. Issues related to Local Coverage Determination revisions specifically in pathways for Continuous Glucose Monitors (CGM). Issues related to National Coverage Determination revisions specifically in reference to durable infusion insulin pumps. Issues related to Prior Authorizations in Medicare Advantage plans. Issues related to support of Improving Seniors' Timely Access to Care Act. Issues related to CMS finalized rule, DMEPOS Home Health Rule. Issues related to expansion of Competitive Bidding Program and implementation of CMS finalized rule relating to DMEPOS Home Health Rule. Issues related to combatting fraud, waste and abuse in the Medicare program - specifically related to the way continuous glucose monitors are billed in Medicare and potential solutions to vet durable medical equipment vendors at CMS. Issues related to wearable health care devices.
Source: Senate LDA
Issues related to the disease of diabetes, diabetes therapies, automated insulin delivery devices, and management of the disease of diabetes. Issues related to medical devices and medical device technologies. Issues related to Pharmacy Benefit Manager (PBM) reform proposals, PBM transparency and potential PBM proposals related to talks of future budget reconciliation package. Issues related to the reintroduction of the DIABETES Act (S.4037) in the 119th Congress. Issues related to artificial intelligence (AI) and predictive algorithms in medical devices and medical device technology. Issues related to tariffs and trade and the Sec. 232 Tariff investigation related to Medical Devices. Issues related to Local Coverage Determination revisions specifically in pathways for Continuous Glucose Monitors (CGM). Issues related to National Coverage Determination revisions specifically in reference to durable infusion insulin pumps. Issues related to Prior Authorizations in Medicare Advantage plans. Issues related to support of Improving Seniors' Timely Access to Care Act. Issues related to CMS finalized rule, DMEPOS Home Health Rule. Issues related to expansion of Competitive Bidding Program and implementation of CMS finalized rule relating to DMEPOS Home Health Rule. Issues related to combatting fraud, waste and abuse in the Medicare program - specifically related to the way continuous glucose monitors are billed in Medicare and potential solutions to vet durable medical equipment vendors at CMS. Issues related to wearable health care devices.
Issues related to the disease of diabetes, diabetes therapies and management of the disease of diabetes. Issues related to medical devices and medical device technology. Issues related to medical device sterilization methods. Issues related to Pharmacy Benefit Managers (PBMs) - no specific bills, but general discussions on impacts to medical devices in the pharmacy channel and impacts to patients. Issues in support of S.4532 H.R. 4532 - prior authorization reform. Issues related to real world evidence and real world data pertaining to medical devices and approval pathways. Issues related to artificial intelligence and predictive algorithms in medical device technology and innovations. Issues related to the filing of S. 5502 - DIABETES Act
Issues related to the disease of diabetes, diabetes therapies and management of the disease of diabetes. Issues related to medical devices and medical device technology. Issues related to medical device sterilization methods. Issues related to the Indian Health Service Issues related to Pharmacy Benefit Managers (PBMs) - no specific bills, but general discussions on impacts to medical devices in the pharmacy channel and impacts to patients. Issues in support of S.4532 H.R. 4532 - prior authorization reform. Issues related to real world evidence and real world data pertaining to medical devices and approval pathways. Issues related to artificial intelligence and predictive algorithms in medical device technology and innovations.
Improving Seniors’ Timely Access to Care Act of 2024
Client: INSULET CORPORATION · Firm: INSULET CORPORATION
Issues related to the disease of diabetes, diabetes therapies and management of the disease of diabetes. Issues related to medical devices and medical device technology. Issues related to medical device sterilization methods. Issues related to Pharmacy Benefit Managers (PBMs) - no specific bills, but general discussions on impacts to medical devices in the pharmacy channel and impacts to patients. Issues in support of S.4532 H.R. 4532 - prior authorization reform. Issues related to real world evidence and real world data pertaining to medical devices and approval pathways. Issues related to artificial intelligence and predictive algorithms in medical device technology and innovations. Issues related to the filing of S. 5502 - DIABETES Act
Improving Seniors’ Timely Access to Care Act of 2024
Client: INSULET CORPORATION · Firm: INSULET CORPORATION
Issues related to the disease of diabetes, diabetes therapies and management of the disease of diabetes. Issues related to medical devices and medical device technology. Issues related to medical device sterilization methods. Issues related to the Indian Health Service Issues related to Pharmacy Benefit Managers (PBMs) - no specific bills, but general discussions on impacts to medical devices in the pharmacy channel and impacts to patients. Issues in support of S.4532 H.R. 4532 - prior authorization reform. Issues related to real world evidence and real world data pertaining to medical devices and approval pathways. Issues related to artificial intelligence and predictive algorithms in medical device technology and innovations.
Issues related to the disease of diabetes, diabetes therapies and management of the disease of diabetes. Issues related to medical devices and medical device technology. Issues related to medical device sterilization methods. Issues related to Pharmacy Benefit Managers (PBMs) - no specific bills, but general discussions on impacts to medical devices in the pharmacy channel and impacts to patients. Issues in support of S.4532 H.R. 4532 - prior authorization reform. Issues related to real world evidence and real world data pertaining to medical devices and approval pathways. Issues related to artificial intelligence and predictive algorithms in medical device technology and innovations. Issues related to the filing of S. 5502 - DIABETES Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
INSULET CORPORATION via INSULET CORPORATION
2026 · second_quarter · Q2
Issues related to the disease of diabetes, diabetes therapies, automated insulin delivery devices, and management of the disease of diabetes. Issues related to medical devices and medical device technologies. Issues related to Pharmacy Benefit Manager (PBM) reform proposals, PBM transparency and potential PBM proposals related to talks of future budget reconciliation package. Issues related to the reintroduction of the DIABETES Act (S.4037) in the 119th Congress. Issues related to artificial intelligence (AI) and predictive algorithms in medical devices and medical device technology. Issues related to tariffs and trade and the Sec. 232 Tariff investigation related to Medical Devices. Issues related to Local Coverage Determination revisions specifically in pathways for Continuous Glucose Monitors (CGM). Issues related to National Coverage Determination revisions specifically in reference to durable infusion insulin pumps. Issues related to Prior Authorizations in Medicare Advantage plans. Issues related to support of Improving Seniors' Timely Access to Care Act. Issues related to CMS finalized rule, DMEPOS Home Health Rule. Issues related to expansion of Competitive Bidding Program and implementation of CMS finalized rule relating to DMEPOS Home Health Rule. Issues related to combatting fraud, waste and abuse in the Medicare program - specifically related to the way continuous glucose monitors are billed in Medicare and potential solutions to vet durable medical equipment vendors at CMS. Issues related to wearable health care devices.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
INSULET CORPORATION via INSULET CORPORATION
2026 · first_quarter · Q1
Issues related to the disease of diabetes, diabetes therapies, automated insulin delivery devices, and management of the disease of diabetes. Issues related to medical devices and medical device technologies. Issues related to Pharmacy Benefit Manager (PBM) reform proposals, PBM transparency and potential PBM proposals related to talks of future budget reconciliation package. Issues related to the reintroduction of the DIABETES Act (S.4037) in the 119th Congress. Issues related to artificial intelligence (AI) and predictive algorithms in medical devices and medical device technology. Issues related to tariffs and trade and the Sec. 232 Tariff investigation related to Medical Devices. Issues related to Local Coverage Determination revisions specifically in pathways for Continuous Glucose Monitors (CGM). Issues related to National Coverage Determination revisions specifically in reference to durable infusion insulin pumps. Issues related to Prior Authorizations in Medicare Advantage plans. Issues related to support of Improving Seniors' Timely Access to Care Act. Issues related to CMS finalized rule, DMEPOS Home Health Rule. Issues related to expansion of Competitive Bidding Program and implementation of CMS finalized rule relating to DMEPOS Home Health Rule. Issues related to wearable health care devices.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
INSULET CORPORATION via INSULET CORPORATION
2025 · fourth_quarter · Q4
Issues related to the disease of diabetes, diabetes therapies, automated insulin delivery devices, and management of the disease of diabetes. Issues related to medical devices and medical device technologies. Issues related to Pharmacy Benefit Manager (PBM) reform proposals, PBM transparency and potential PBM proposals related to budget reconciliation package. Issues related to the reintroduction or possible reintroduction of the DIABETES Act in the 119th Congress. Issues related to artificial intelligence (AI) and predictive algorithms in medical devices and medical device technology. Issues related to tariffs and trade. Issues related to Local Coverage Determination revisions specifically in pathways for Continuous Glucose Monitors (CGM). Issues related to National Coverage Determination revisions specifically in reference to insulin pumps. Issues related to Prior Authorizations in Medicare Advantage plans. Issues related to support of Improving Seniors' Timely Access to Care Act. Issues related to CMS notice of proposed rule, DMEPOS Home Health Rule. Issues related to expansion of Competitive Bidding Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
INSULET CORPORATION via INSULET CORPORATION
2025 · third_quarter · Q3
Issues related to the disease of diabetes, diabetes therapies, automated insulin delivery devices, and management of the disease of diabetes. Issues related to medical devices and medical device technologies. Issues related to Pharmacy Benefit Manager (PBM) reform proposals, PBM transparency and potential PBM proposals related to budget reconciliation package. Issues related to the reintroduction or possible reintroduction of the DIABETES Act in the 119th Congress. Issues related to artificial intelligence (AI) and predictive algorithms in medical devices and medical device technology. Issues related to tariffs and trade. Issues related to Local Coverage Determination revisions specifically in pathways for Continuous Glucose Monitors (CGM). Issues related to Prior Authorizations in Medicare Advantage plans. Issues related to support of Improving Seniors' Timely Access to Care Act. Issues related to CMS notice of proposed rule, DMEPOS Home Health Rule.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
INSULET CORPORATION via INSULET CORPORATION
2025 · second_quarter · Q2
Issues related to the disease of diabetes, diabetes therapies, automated insulin delivery devices, and management of the disease of diabetes. Issues related to medical devices and medical device technologies. Issues related to Pharmacy Benefit Manager (PBM) reform proposals, PBM transparency and potential PBM proposals related to budget reconciliation package. Issues related to the reintroduction or possible reintroduction of the DIABETES Act in the 119th Congress. Issues related to artificial intelligence (AI) and predictive algorithms in medical devices and medical device technology. Issues related to tariffs and trade. Issues related to Local Coverage Determination revisions specifically in pathways for Continuous Glucose Monitors (CGM). Issues related to Prior Authorizations in Medicare Advantage plans. Issues related to support of Improving Seniors' Timely Access to Care Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
INSULET CORPORATION via INSULET CORPORATION
2025 · first_quarter · Q1
Issues related to the disease of diabetes, diabetes therapies, automated insulin delivery devices, and management of the disease of diabetes. Issues related to medical devices and medical device technologies. Issues related to Pharmacy Benefit Manager (PBM) reform proposals, PBM transparency and potential PBM proposals related to budget reconciliation package. Issues related to the reintroduction or possible reintroduction of the DIABETES Act in the 119th Congress. Issues related to artificial intelligence (AI) and predictive algorithms in medical devices and medical device technology. Issues related to tariffs and trade. Issues related to Local Coverage Determination revisions specifically in pathways for Continuous Glucose Monitors (CGM).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
INSULET CORPORATION via INSULET CORPORATION
2024 · fourth_quarter · Q4
Issues related to the disease of diabetes, diabetes therapies and management of the disease of diabetes. Issues related to medical devices and medical device technology. Issues related to medical device sterilization methods. Issues related to Pharmacy Benefit Managers (PBMs) - no specific bills, but general discussions on impacts to medical devices in the pharmacy channel and impacts to patients. Issues in support of S.4532 H.R. 4532 - prior authorization reform. Issues related to real world evidence and real world data pertaining to medical devices and approval pathways. Issues related to artificial intelligence and predictive algorithms in medical device technology and innovations. Issues related to the filing of S. 5502 - DIABETES Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
INSULET CORPORATION via INSULET CORPORATION
2024 · third_quarter · Q3
Issues related to the disease of diabetes, diabetes therapies and management of the disease of diabetes. Issues related to medical devices and medical device technology. Issues related to medical device sterilization methods. Issues related to the Indian Health Service Issues related to Pharmacy Benefit Managers (PBMs) - no specific bills, but general discussions on impacts to medical devices in the pharmacy channel and impacts to patients. Issues in support of S.4532 H.R. 4532 - prior authorization reform. Issues related to real world evidence and real world data pertaining to medical devices and approval pathways. Issues related to artificial intelligence and predictive algorithms in medical device technology and innovations.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
INSULET CORPORATION via INSULET CORPORATION
2024 · second_quarter · Q2
Issues related to the disease of diabetes, diabetes therapies and management of the disease of diabetes. Issues related to medical devices and medical device technology. Issues related to medical device sterilization methods. Issues related to the Indian Health Service Issues related to Pharmacy Benefit Managers (PBMs) - no specific bills, but general discussions on impacts to medical devices in the pharmacy channel and impacts to patients. Issues related to real world evidence and real world data pertaining to medical devices and approval pathways. Issues related to artificial intelligence and predictive algorithms in medical device technology and innovations.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
INSULET CORPORATION via INSULET CORPORATION
2024 · first_quarter · Q1
Issues related to the disease of diabetes, diabetes therapies and management of the disease of diabetes. Issues related to medical devices and medical device technology. Issues related to medical device sterilization methods. Issues related to the State of Texas and the Texas State Plan Amendment request regarding how the state will administer aspects of Medicaid. Issues related to Pharmacy Benefit Managers (PBMs) - no specific bills, but general discussions on impacts to medical devices in the pharmacy channel and impacts to patients. Issues related to real world evidence and real world data pertaining to medical devices and approval pathways. Issues related to artificial intelligence and predictive algorithms in medical device technology and innovations.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
INSULET CORPORATION via INSULET CORPORATION
2023 · fourth_quarter · Q4
Issues related to the disease of diabetes, diabetes therapies and management of the disease of diabetes. Issues related to medical devices and medical device technology. Issues related to medical device sterilization methods. Issues related to the State of Texas and the Texas State Plan Amendment request regarding how the state will administer aspects of Medicaid. Issues related to the State of Oklahoma and Oklahoma Medicaid. Issues related to Pharmacy Benefit Managers (PBMs) - no specific bills, but general discussions on impacts to medical devices in the pharmacy channel and impacts to patients.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
INSULET CORPORATION via INSULET CORPORATION
2023 · third_quarter · Q3
Issues related to the disease of diabetes, diabetes therapies and management of the disease of diabetes. Issues related to medical devices and medical device technology. Issues related to medical device sterilization methods. Issues related to the State of Texas and the Texas State Plan Amendment request regarding how the state will administer aspects of Medicaid. Issues related to the State of Oklahoma and Oklahoma Medicaid. Issues related to Pharmacy Benefit Managers (PBMs) - no specific bills, but general discussions on impacts to medical devices in the pharmacy channel and impacts to patients.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
INSULET CORPORATION via INSULET CORPORATION
2023 · second_quarter · Q2
Issues related to the disease of diabetes, diabetes therapies and management of the disease of diabetes. Issues related to medical devices and medical device technology. Issues related to medical device sterilization methods. Issues related to the State of Texas and the Texas State Plan Amendment request regarding how the state will administer aspects of Medicaid. Issues related to Pharmacy Benefit Managers (PBMs) - no specific bills, but general discussions on impacts to medical devices in the pharmacy channel and impacts to patients.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
INSULET CORPORATION via INSULET CORPORATION
2023 · first_quarter · Q1
Issues related to the disease of diabetes, diabetes therapies and management of the disease of diabetes. Issues related to medical devices and medical device technology. Issues related to medical device sterilization methods. Issues related to the State of Texas and the Texas State Plan Amendment request regarding how the state will administer aspects of Medicaid. Issues related to Pharmacy Benefit Managers (PBMs) - no specific bills, but general discussions on impacts to medical devices in the pharmacy channel and impacts to patients.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
INSULET CORPORATION via INSULET CORPORATION
2022 · fourth_quarter · Q4
Issues related to the Medical Device industry and the impact of Federal policies Issues related to the care and management of Diabetes and the impact of Federal policies Issues related to telehealth, reimbursement codes and Federal policies following the Public Health Emergency
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
INSULET CORPORATION via INSULET CORPORATION
2022 · third_quarter · Q3
Issues related to the Medical Device industry and the impact of Federal policies Issues related to the care and management of Diabetes and the impact of Federal policies Issues related to telehealth, reimbursement codes and Federal policies following the Public Health Emergency
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
INSULET CORPORATION via INSULET CORPORATION
2022 · second_quarter · Q2
Issues related to the Medical Device industry and the impact of Federal policies Issues related to the care and management of Diabetes and the impact of Federal policies Issues related to telehealth, reimbursement codes and Federal policies following the Public Health Emergency
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
INSULET CORPORATION via INSULET CORPORATION
2022 · first_quarter · Q1
Issues related to the Medical Device industry and the impact of Federal policies Issues related to the care and management of Diabetes and the impact of Federal policies Issues related to telehealth, reimbursement codes and Federal policies following the Public Health Emergency
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
INSULET CORPORATION via INSULET CORPORATION
2021 · fourth_quarter · 4A
Issues related to the Medical Device industry and the impact of Federal policies Issues related to the care and management of Diabetes and the impact of Federal policies Issues related to telehealth, reimbursement codes and Federal policies following the Public Health Emergency
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
INSULET CORPORATION via INSULET CORPORATION
2021 · fourth_quarter · RR
Medical Device Manufacturing, medicare/medicaid reimbursement, market access issues, telehealth issues, data and cybersecurity, digital health, diabetes disease specific issues
Medical Device Manufacturing, medicare/medicaid reimbursement, market access issues, telehealth issues, data and cybersecurity, digital health, diabetes disease specific issues
Medical Device Manufacturing, medicare/medicaid reimbursement, market access issues, telehealth issues, data and cybersecurity, digital health, diabetes disease specific issues
Medical Device Manufacturing, medicare/medicaid reimbursement, market access issues, telehealth issues, data and cybersecurity, digital health, diabetes disease specific issues
Medical Device Manufacturing, medicare/medicaid reimbursement, market access issues, telehealth issues, data and cybersecurity, digital health, diabetes disease specific issues
Medical Device Manufacturing, medicare/medicaid reimbursement, market access issues, telehealth issues, data and cybersecurity, digital health, diabetes disease specific issues